• Policy
• Prior approval not required for reimb of Strensiq in KOR
• by Lee, Tak-Sun Apr 1, 2024 05:29am

• Policy
• The NHI Trade Union says, 'NHIS should join the DREC'...
• by Lee, Tak-Sun Mar 29, 2024 05:53am

• Policy
• "Seek social consensus, shift away from 2,000 quota"
• by Lee, Jeong-Hwan Mar 29, 2024 05:53am

• Policy
• NHIS expands info disclosure about drug pricing negotiations
• by Lee, Tak-Sun Mar 29, 2024 05:53am

• Policy
• JW Pharmaceutical agrees on RSA renewal terms for Hemlibra
• by Lee, Tak-Sun Mar 29, 2024 05:53am

• Policy
• LG Chem expands its Zemimet SR Tab lineup
• by Lee, Tak-Sun Mar 28, 2024 05:52am

• Policy
• Ruling party will focus on fostering Korea's pharma industry
• by Lee, Jeong-Hwan Mar 27, 2024 06:04am

• Policy
• 'Trajenta-duo' generics as SR tablets…55 approved items
• by Lee, Hye-Kyung Mar 27, 2024 06:04am

• Policy
• MFDS reviews enacting a separate and special law for drugs
• by Lee, Hye-Kyung Mar 26, 2024 06:30am

• Policy
• Daewoong joins in competition in the Forxiga generic market
• by Lee, Tak-Sun Mar 26, 2024 06:30am